This inventor holds 1 USPTO granted patent. Top assignee: Health Research, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Therapy by Feng Geng
Introduction
Feng Geng is an accomplished inventor based in Columbus, OH (US). He has made significant contributions to the field of cancer therapy, particularly through his innovative research on isothiocyanates. His work focuses on developing methods for the delivery and use of these compounds in the prevention and treatment of bladder cancer.
Latest Patents
Feng Geng holds a patent titled "Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer." This patent describes a unique composition that combines broccoli seed and mustard seed. The broccoli seed undergoes a baking process at a temperature of at least 200 degrees Fahrenheit for a minimum of 60 minutes, followed by a pressurized heat treatment at the same temperature and a pressure of at least 10 pounds per square inch for at least 5 minutes. The method aims to administer isothiocyanates or their derivatives orally to inhibit the growth and recurrence of bladder cancer.
Career Highlights
Feng Geng has demonstrated a strong commitment to advancing cancer research through his innovative approaches. His patent reflects his dedication to finding effective therapies that can improve patient outcomes. With 1 patent to his name, he continues to explore new avenues in the field of nutraceutical compositions.
Collaborations
Feng has collaborated with notable colleagues, including Yuesheng Zhang and Joseph D Paonessa. Their combined expertise contributes to the ongoing research and development of effective cancer therapies.
Conclusion
Feng Geng's innovative work in the field of cancer therapy showcases the potential of isothiocyanates in the fight against bladder cancer. His contributions are paving the way for new treatment options that may significantly benefit patients in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile